Literature DB >> 12644273

Signalling pathways involved in the short-term potentiation of dopamine release by BDNF.

Julian Goggi1, Ian A Pullar, Stephen L Carney, Henry F Bradford.   

Abstract

Brain-derived neurotrophic factor (BDNF) has been shown to modulate synaptic plasticity in the corpus striatum in vitro by activation of the tyrosine kinase linked receptor, TrkB. However, the signalling pathways that mediate this modulation of plasticity are poorly understood. Three proteins mediating signalling pathways are activated by the binding of BDNF to TrkB: phosphoinositol-3 kinase (PI3K); Ras-MEK and phospholipase C-gamma (PLCgamma). The present study investigates which of these pathways are necessary for BDNF-mediated potentiation of synaptic output of dopamine from slices and synaptosomes of rat corpus striatum. The results indicate that activation of the PI3K and Ras-MEK pathways, but not PLCgamma, are involved. Inhibitors of transcription and translation had no effect on the potentiation of depolarisation-stimulated (15 mM KCl) dopamine release mediated by BDNF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12644273     DOI: 10.1016/s0006-8993(03)02234-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  21 in total

1.  Presynaptic dopamine dynamics in striatal brain slices with fast-scan cyclic voltammetry.

Authors:  Francis K Maina; Madiha Khalid; Aaron K Apawu; Tiffany A Mathews
Journal:  J Vis Exp       Date:  2012-01-12       Impact factor: 1.355

2.  Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodents.

Authors:  Kirill O Eremin; Vladimir S Kudrin; Pirjo Saransaari; Simo S Oja; Igor A Grivennikov; Nikolay F Myasoedov; Kirill S Rayevsky
Journal:  Neurochem Res       Date:  2005-12       Impact factor: 3.996

3.  Dose-dependent effects of wheel running on cocaine-seeking and prefrontal cortex Bdnf exon IV expression in rats.

Authors:  Alexis B Peterson; Jean M Abel; Wendy J Lynch
Journal:  Psychopharmacology (Berl)       Date:  2013-10-31       Impact factor: 4.530

4.  Systemic Delivery of a Brain-Penetrant TrkB Antagonist Reduces Cocaine Self-Administration and Normalizes TrkB Signaling in the Nucleus Accumbens and Prefrontal Cortex.

Authors:  Michel M M Verheij; Leandro F Vendruscolo; Lucia Caffino; Giuseppe Giannotti; Maxime Cazorla; Fabio Fumagalli; Marco A Riva; Judith R Homberg; George F Koob; Candice Contet
Journal:  J Neurosci       Date:  2016-08-03       Impact factor: 6.167

Review 5.  Stress, sex, and motivated behaviors.

Authors:  Abigail Laman-Maharg; Brian C Trainor
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

6.  Cysteamine alleviates early brain injury via reducing oxidative stress and apoptosis in a rat experimental subarachnoid hemorrhage model.

Authors:  Zong-Yong Zhang; Ming-Feng Yang; Tao Wang; Da-Wei Li; Yun-Lin Liu; Jin-Hui Zhang; Bao-Liang Sun
Journal:  Cell Mol Neurobiol       Date:  2014-12-20       Impact factor: 5.046

7.  Ethanol-induced increases in extracellular dopamine are blunted in brain-derived neurotrophic factor heterozygous mice.

Authors:  Kelly E Bosse; Tiffany A Mathews
Journal:  Neurosci Lett       Date:  2010-12-14       Impact factor: 3.046

8.  Environmental enrichment increases the in vivo extracellular concentration of dopamine in the nucleus accumbens: a microdialysis study.

Authors:  Gregorio Segovia; Alberto Del Arco; Marta De Blas; Pedro Garrido; Francisco Mora
Journal:  J Neural Transm (Vienna)       Date:  2010-08-13       Impact factor: 3.575

9.  Dopaminergic variants in siblings at high risk for autism: Associations with initiating joint attention.

Authors:  Devon N Gangi; Daniel S Messinger; Eden R Martin; Michael L Cuccaro
Journal:  Autism Res       Date:  2016-03-15       Impact factor: 5.216

Review 10.  Brain-derived neurotrophic factor and cocaine addiction.

Authors:  Jacqueline F McGinty; Timothy W Whitfield; William J Berglind
Journal:  Brain Res       Date:  2009-09-02       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.